Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New CDK8 and/or CDK19 inhibitors synthesized at the Dana-Farber Cancer Institute

June 25, 2021

Sinovent identifies new GTPase KRAS G12C mutant inhibitors

June 25, 2021

Kyorin Pharmaceutical and collaborators describe protein G9a inhibitors

June 25, 2021

New GTPase KRAS inhibitors discovered at REVOLUTION Medicines

June 25, 2021

Wuhan LL Science and Technology Development Co. patents P2X4 receptor antagonists

June 25, 2021

DTx Pharma presents new compounds for DMD

June 23, 2021

Lupin synthesizes new SOS1 inhibitors

June 23, 2021

Captor Therapeutics identifies new CRBN-targeting compounds

June 23, 2021

Theravance Biopharma presents JAK3 inhibitors

June 23, 2021

Taiho Pharmaceutical and Astex Therapeutics patent GTPase KRAS inhibitors

June 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...